Top 50 SARS-CoV-2 Articles | Nature Communications

Our most downloaded articles from 2020 on the ongoing pandemic

Published in Microbiology

Top 50 SARS-CoV-2 Articles | Nature Communications
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

The 50 most downloaded Nature Communications articles* on SARS-CoV-2 published in 2020 illustrate the collaborative efforts of the international community to combat the ongoing pandemic. These papers highlight valuable research into the biology of coronavirus infection, its detection, treatment as well as into vaccine development and the epidemiology of the disease.

Follow #NCOMTop50 on social media for all featured content.

* Data obtained from SN Insights (based on Digital Science's Dimensions) and has been normalised to account for articles published later in the year.


Image: fotograzia, via Getty

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Microbiology
Life Sciences > Biological Sciences > Microbiology

Related Collections

With Collections, you can get published faster and increase your visibility.

Women's Health

A selection of recent articles that highlight issues relevant to the treatment of neurological and psychiatric disorders in women.

Publishing Model: Hybrid

Deadline: Ongoing

Tumor Microenvironment Crosstalk and Therapeutic Implications

With this cross-journal Collection, the editors at Nature Immunology, Nature Communications, Communications Medicine and Scientific Reports invite manuscripts that highlight cutting-edge research on TME crosstalk and its therapeutic implications. Topics of interest include immune modulation and checkpoint pathways, cancer-associated fibroblasts and stromal remodeling, angiogenesis and vascular normalization, metabolic reprogramming within the TME, and the role of microbiota in tumor-immune dynamics. We also welcome studies on novel therapeutic approaches that exploit TME vulnerabilities to advance cancer treatment.

Publishing Model: Hybrid

Deadline: Nov 02, 2026